Die EU startet gemeinsam mit der Queensland University of Technology, in Brisbane, ein Masterstudium für Biofabrication, namens Biofab.
Geleitet wird das Masterstudium von dem niederländischen Dr. Jos Malda von der Universitair Medisch Centrum in Utrecht, das Gegenstück ist Professor Dietmar Hutmacher in Brisbane. Dabei werden 40 Studenten, jeweils 20 aus der EU und 20 aus Australien, in das Programm aufgenommen.
Aus der Application:
The emerging technology of additive manufacturing (also known as 3D printing) is becoming widely reported in the global media and academia as a transformative one. This approach uses a layer-by- layer principle for manufacturing, where physical objects are produced through automation. It is expected that additive manufacturing success will be extended to produce biological tissues, to address the many health challenges facing an increasingly aging population. Biofabrication could be used to repair tissue damaged by trauma, disease or cancer, while many diagnostic applications and pharmaceutical systems could benefit from technologies developing. An education in biofabrication also provides an effective platform for a career in additive manufacturing, which is broader and impact areas beyond medicine.